Conference Proceedings
Analysis of resistance mechanisms to osimertinib in patients with EGFR T790M advanced NSCLC from the AURA3 study
VA Papadimitrakopoulou, Y-L Wu, J-Y Han, M-J Ahn, SS Ramalingam, T John, I Okamoto, JC-H Yang, KC Bulusu, G Laus, B Collins, JC Barrett, J Chmielecki, TSK Mok
ANNALS OF ONCOLOGY | OXFORD UNIV PRESS | Published : 2018
Grants
Funding Acknowledgements
AstraZeneca, Cambridge, UK.